HCWB
HCW Biologics·NASDAQ
--
--(--)
--
--(--)
5.70 / 10
Netural
HCW Biologics presents balanced fundamental metrics (score 5.7/10). Strong points include a healthy inventory turnover ratio and interest coverage ratio, while weak year-over-year revenue growth warrants caution. This leads to a selective investment appraisal.
Analysis Checks(7/10)
Revenue-MV
Value-7.57
Score1/3
Weight8.58%
1M Return3.98%
Value-7.57
Score1/3
Weight8.58%
1M Return3.98%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.06%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.06%
1M Return-1.23%
PB-ROE
Value5.52
Score3/3
Weight28.65%
1M Return13.65%
Value5.52
Score3/3
Weight28.65%
1M Return13.65%
Operating revenue (YoY growth rate %)
Value-98.75
Score1/3
Weight-0.90%
1M Return-0.52%
Value-98.75
Score1/3
Weight-0.90%
1M Return-0.52%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.70%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.70%
1M Return-0.98%
Total operating revenue (YoY growth rate %)
Value-98.75
Score1/3
Weight-1.04%
1M Return-0.60%
Value-98.75
Score1/3
Weight-1.04%
1M Return-0.60%
Profit-MV
Value0.47
Score2/3
Weight19.91%
1M Return8.99%
Value0.47
Score2/3
Weight19.91%
1M Return8.99%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.15%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.15%
1M Return-1.25%
Asset-MV
Value-0.51
Score3/3
Weight31.59%
1M Return11.94%
Value-0.51
Score3/3
Weight31.59%
1M Return11.94%
Cash-MV
Value-0.07
Score2/3
Weight19.12%
1M Return8.80%
Value-0.07
Score2/3
Weight19.12%
1M Return8.80%
Revenue-MV
Value-7.57
Score1/3
Weight8.58%
1M Return3.98%
Value-7.57
Score1/3
Weight8.58%
1M Return3.98%
Total operating revenue (YoY growth rate %)
Value-98.75
Score1/3
Weight-1.04%
1M Return-0.60%
Value-98.75
Score1/3
Weight-1.04%
1M Return-0.60%
Inventory turnover ratio
Value47.88
Score2/3
Weight-2.06%
1M Return-1.23%
Value47.88
Score2/3
Weight-2.06%
1M Return-1.23%
Profit-MV
Value0.47
Score2/3
Weight19.91%
1M Return8.99%
Value0.47
Score2/3
Weight19.91%
1M Return8.99%
PB-ROE
Value5.52
Score3/3
Weight28.65%
1M Return13.65%
Value5.52
Score3/3
Weight28.65%
1M Return13.65%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.51
Score2/3
Weight-2.15%
1M Return-1.25%
Value15.51
Score2/3
Weight-2.15%
1M Return-1.25%
Operating revenue (YoY growth rate %)
Value-98.75
Score1/3
Weight-0.90%
1M Return-0.52%
Value-98.75
Score1/3
Weight-0.90%
1M Return-0.52%
Asset-MV
Value-0.51
Score3/3
Weight31.59%
1M Return11.94%
Value-0.51
Score3/3
Weight31.59%
1M Return11.94%
Net profit / Total profit (%)
Value100.00
Score2/3
Weight-1.70%
1M Return-0.98%
Value100.00
Score2/3
Weight-1.70%
1M Return-0.98%
Cash-MV
Value-0.07
Score2/3
Weight19.12%
1M Return8.80%
Value-0.07
Score2/3
Weight19.12%
1M Return8.80%
Is HCWB undervalued or overvalued?
- HCWB scores 5.70/10 on fundamentals and holds a Fair valuation at present. Backed by its 0.00% ROE, -2855.80% net margin, -0.16 P/E ratio, -1.62 P/B ratio, and 65.76% earnings growth, these metrics solidify its Netural investment rating.
